NIKUNJKUMAR MODI: Open Payments
NPI 1003131343 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,012 in 53 payments from 7 companies in 2025. Trend: 2023 $18,088 · 2024 $24,928 · 2025 $27,012
Speaker / faculty: $25,096Food & beverage: $989Travel & lodging: $927
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $20,800 |
| ABBVIE INC. | 20 | $5,994 |
| Janssen Pharmaceuticals, Inc | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Alkermes, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $32 |
Products named: UZEDY, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY, ARISTADA, Auvelity, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
